Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2026-01-31 @ 8:24 AM
Study NCT ID:
NCT03078556
Status:
COMPLETED
Last Update Posted:
2019-02-21
First Post:
2017-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bioequivalence Study of Fixed Dose Versus Single Entities of Dolutegravir and Lamivudine
Sponsor:
ViiV Healthcare
Organization: